Encarnación Navarro, J.A.; Morillo MacÃas, V.; Borrás Calbo, M.; De la Fuente Muñoz, I.; Lozano MartÃnez, A.; GarcÃa MartÃnez, V.; Fernández Fornos, L.; Guijarro Roche, M.; Amr Rey, O.; GarcÃa Gómez, R.
Multicenter Real-World Study: 432 Patients with Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer. Curr. Oncol. 2025, 32, 119.
https://doi.org/10.3390/curroncol32030119
AMA Style
Encarnación Navarro JA, Morillo MacÃas V, Borrás Calbo M, De la Fuente Muñoz I, Lozano MartÃnez A, GarcÃa MartÃnez V, Fernández Fornos L, Guijarro Roche M, Amr Rey O, GarcÃa Gómez R.
Multicenter Real-World Study: 432 Patients with Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer. Current Oncology. 2025; 32(3):119.
https://doi.org/10.3390/curroncol32030119
Chicago/Turabian Style
Encarnación Navarro, Juan A., Virginia Morillo MacÃas, MarÃa Borrás Calbo, Isabel De la Fuente Muñoz, Antonio Lozano MartÃnez, Vicente GarcÃa MartÃnez, Luis Fernández Fornos, Miriam Guijarro Roche, Osamah Amr Rey, and Raquel GarcÃa Gómez.
2025. "Multicenter Real-World Study: 432 Patients with Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer" Current Oncology 32, no. 3: 119.
https://doi.org/10.3390/curroncol32030119
APA Style
Encarnación Navarro, J. A., Morillo MacÃas, V., Borrás Calbo, M., De la Fuente Muñoz, I., Lozano MartÃnez, A., GarcÃa MartÃnez, V., Fernández Fornos, L., Guijarro Roche, M., Amr Rey, O., & GarcÃa Gómez, R.
(2025). Multicenter Real-World Study: 432 Patients with Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer. Current Oncology, 32(3), 119.
https://doi.org/10.3390/curroncol32030119
